and/or

324 Blog posts found

In the Clinic

Pumped Up: Implanted Chemotherapy Device Improves Survival when Colorectal Cancer Spreads to the Liver

A retrospective study from MSK has found that colorectal cancer patients with liver metastases live an average of two years longer when they receive an additional treatment called hepatic arterial infusion (HAI).

Image of liver with tumors

Finding

Blood Will Tell: Scientists Find Clues to Immunotherapy Responders and Non-Responders

Why do some patients respond to immunotherapy while others do not? Blood may hold the answer.

photo of blood vials

Finding

#AACR17: Novel Drug Advancing to Phase II Basket Trial of Solid Tumors

Learn more about entrectinib, a targeted therapy being evaluated in patients with solid tumors.

Physician standing in front of a whiteboard

Finding

#AACR17: Researchers Shed Light on Biological Activity of a New, First-in-Class Immunotherapy

A team at MSK uncovered how TRX518, a new immunotherapy drug in early development, works in the body.

Grey T lymphocytes

Finding

#AACR17: New Data Show Some Patients with Melanoma Live Longer When Receiving Immunotherapy Combination

For some patients with metastatic melanoma, a combination of two immunotherapies works better than either drug alone.

Finding

#AACR17: Study Explores Best Time to Give CAR T Cell Therapy

Leukemia patients may do better on CAR T cell therapy when they are treated early, before their disease relapses.

immune cells

Finding

#AACR17: Basket Trial for Experimental Drug Shows Promising Early Results

Neratinib, which targets mutations that drive cancer growth, is showing promise for treating several types of cancer.

David Hyman and Robin Gillespie

In the Clinic

Intestinal Bacteria May Affect Risk of Cancer Returning after Bone Marrow Transplantation

Learn how a patient’s intestinal bacteria may influence the risk of cancers such as leukemia or lymphoma returning after bone marrow transplantation.

Illustration of intestinal tract with magnifying glass held over it revealing various microbes.

In the Lab

CRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level

What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.

CAR T cells attacking cancer

In the Lab

Could a Topical Cream Prevent Lymphedema? Study in Mice Suggests Yes

By blocking a source of inflammation in the skin, it may be possible to prevent or treat this debilitating cancer complication.